Acurex Biosciences
AB
About
Acurex Biosciences is a biotechnology company focused on developing novel therapeutics for neurological disorders, with a particular emphasis on Parkinson's disease. The company leverages scientific advancements to create new medicines. They have announced receiving a grant from Aligning Science Across Parkinson’s (ASAP) in partnership with The Michael J.
Competitors & alternatives (6)
Acurex Biosciences alternatives 
Key facts
At-a-glance profile data
- Website
- acurexbio.com
- Headquarters
- San Carlos, California, USA
- Founded
- 2019
- Total funding
- $1M (Grant)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2023 | Grant | $1M | - |
Add first review
Frequently asked
What does Acurex Biosciences do?
Fox Foundation for Parkinson’s Research (MJFF) to support their research.
How much funding has Acurex Biosciences raised?
Acurex Biosciences has raised a total of $1M in funding. The most recent round on record is Grant.
What is Acurex Biosciences's current status?
Acurex Biosciences's current operating status is: Inactive.